ShangJ, WanY, LuoC, et al.Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A, 2020; 117(21):11727–11734; doi: 10.1073/pnas.2003138117. Epub 2020 May 6
2.
BarnesCO, JetteCA, AbernathyME, et al.SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature, 2020; 588(7839):682–687; doi: 10.1038/s41586-020-2852-1. Epub 2020 Oct 12
3.
BerthelootD, NaumovskiAL, LanghoffP, et al.RAGE enhances TLR responses through binding and internalization of RNA. J Immunol, 2016; 197(10):4118–4126; doi: 10.049/jimmunol.1502169. Epub 2016 Oct 19
4.
PardiN, HoganMJ, PorterFW, et al.mRNA vaccines—A new era in vaccinology. Nat Rev Drug Discov, 2018; 17(4):261–279; doi: 10.1038/nrd.2017.243
5.
MiyakeK, ShibataT, OhtoU, et al.Mechanisms controlling nucleic acid-sensing Toll-like receptors. Int Immunol, 2018; 30(2):43–51; doi: 10.1093/intimm/dxy016
6.
KarikóK, BucksteinM, NiH, et al.Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity, 2005; 23(2):165–175; doi: 10.1016/j.immuni.2005.06.008
7.
KarikóK, MuramatsuH, WelshFA, et al.Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther, 2008; 16(11):1833–1840; doi: 10.038/mt.2008.200. Epub Sep 16
8.
ReichmuthAM, OberliMA, JaklenecA, et al.mRNA vaccine delivery using lipid nanoparticles. Ther Deliv, 2016; 7(5):319–334; doi: 10.4155/tde-2016-0006
9.
AlmeidaAJ, SoutoE. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev, 2007; 59(6):478–490; doi: 10.1016/j.addr.2007.04.007. Epub May 1
10.
TrougakosIP, TerposE, AlexopoulosH, et al.Adverse effects of COVID-19 mRNA vaccines: The spike hypothesis. Trends Mol Med, 2022; 28(7):542–554; doi: 10.1016/j.molmed.2022.04.007. Epub Apr 21
11.
LiC, ChenY, ZhaoY, et al.Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis, 2022; 74(11):1933–1950; doi: 10.093/cid/ciab707
12.
YonkerLM, SwankZ, BartschYC, et al.Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation, 2023; 4(10):061025.
13.
BilleskovR, BeikzadehB, BerzofskyJA. The effect of antigen dose on T cell-targeting vaccine outcome. Hum Vaccin Immunother, 2019; 15(2):407–411; doi: 10.1080/21645515.2018.1527496. Epub 2018 Oct 25
14.
PainterMM, MathewD, GoelRR, et al.Rapid induction of antigen-specific CD4(+) T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity, 2021; 54(9):2133–2142.e3; doi: 10.1016/j.immuni.2021.08.001. Epub Aug 13
15.
WilliamsDE. Statistics of antibody binding to the spike protein explain the dependence of COVID 19 infection risk on antibody concentration and affinity. Sci Rep, 2022; 12(1):9379; doi: 10.1038/s41598-022-13748-3
